Acute promyelocytic leukemia: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques

Autor(es)

M.L.L.F. Chauffaille ^[1] ; M.S. Figueiredo ^[2] ; R. Beltrani ^[3] ; S.V. Antunes ^[4] ; M. Yamamoto ^[5] ; J. Kerbauy ^[6]

Afiliação do(s) autor(es)

^[1] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

^[2] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

^[3] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

^[4] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

^[5] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

^[6] Universidade Federal de São Paulo. Escola Paulista de Medicina. Disciplina de Hematologia e Hemoterapia - Brasil

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Medical and Biological Research; v. 34, n. 6, p. 735-743, 2001-06-00.

Resumo

Acute promyelocytic leukemia (AML M3) is a well-defined subtype of leukemia with specific and peculiar characteristics. Immediate identification of t(15;17) or the PML/RARA gene rearrangement is fundamental for treatment. The objective of the present study was to compare fluorescent in situ hybridization (FISH), reverse transcriptase-polymerase chain reaction (RT-PCR) and karyotyping in 18 samples (12 at diagnosis and 6 after treatment) from 13 AML M3 patients. Bone marrow samples were submitted to karyotype G-banding, FISH and RT-PCR. At diagnosis, cytogenetics was successful in 10 of 12 samples, 8 with t(15;17) and 2 without. FISH was positive in 11/12 cases (one had no cells for analysis) and positivity varied from 25 to 93% (mean: 56%). RT-PCR was done in 6/12 cases and all were positive. Four of 8 patients with t(15;17) presented positive RT-PCR as well as 2 without metaphases. The lack of RT-PCR results in the other samples was due to poor quality RNA. When the three tests were compared at diagnosis, karyotyping presented the translocation in 80% of the tested samples while FISH and RT-PCR showed the PML/RARA rearrangement in 100% of them. Of 6 samples evaluated after treatment, 3 showed a normal karyotype, 1 persistence of an abnormal clone and 2 no metaphases. FISH was negative in 4 samples studied and 2 had no material for analysis. RT-PCR was positive in 4 (2 of which showed negative FISH, indicating residual disease) and negative in 2. When the three tests were compared after treatment, they showed concordance in 2 of 6 samples or, when there were not enough cells for all tests, concordance between karyotype and RT-PCR in one. At remission, RT-PCR was the most sensitive test in detecting residual disease, as expected (positive in 4/6 samples). An incidence of about 40% of 5' breaks and 60% of 3' breaks, i.e., bcr3 and bcr1/bcr2, respectively, was observed. (AU)

• Processo FAPESP: 97/05832-0 - Identificação de anormalidades cromossômicas em células blásticas de pacientes com leucemia e síndromes mieldisplásicas através de hibridação in situ por fluorescência
• Beneficiário: Maria de Lourdes Lopes Ferrari Chauffaille
• Modalidade de apoio: Auxílio à Pesquisa - Regular